Evidence map›Paper›PMID 28096221›Full record

ArticleDevelopment (Cambridge, England)2017

Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells.

Raul Bardini Bressan, Pooran Singh Dewari, Maria Kalantzaki, Ester Gangoso, Mantas Matjusaitis, Claudia Garcia-Diaz, Carla Blin, Vivien Grant, Harry Bulstrode, Sabine Gogolok and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Targeted disruption of theActa biochimica et biophysica Sinica · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Raul Bardini BressanMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Pooran Singh DewariMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Maria KalantzakiMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Ester GangosoMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Mantas MatjusaitisMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Claudia Garcia-DiazMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Carla BlinMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Vivien GrantMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Harry BulstrodeMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Sabine GogolokMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
William C SkarnesWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Steven M PollardMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK steven.pollard@ed.ac.uk.ORCID 0000-0001-6428-0492
MRC Centre for Regenerative Medicine · GBWellcome Sanger Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M018040/1Cancer Research UK 17368Cancer Research UK 21992Cancer Research UK A19778Medical Research Council MR/K017047/1Medical Research Council MR/L012766/1
6 · The paper itself

Abstract

Mammalian neural stem cell (NSC) lines provide a tractable model for discovery across stem cell and developmental biology, regenerative medicine and neuroscience. They can be derived from foetal or adult germinal tissues and continuously propagated

Indexed as

CRISPR-Cas SystemsAllelesAnimalsBasic Helix-Loop-Helix ProteinsBrain NeoplasmsEpitope MappingEpitopesGene TargetingGliomaGreen Fluorescent ProteinsHomologous RecombinationHumansMiceMice, KnockoutMutationNerve Tissue ProteinsBasic Helix-Loop-Helix ProteinsEpitopesGreen Fluorescent ProteinsNerve Tissue ProteinsOlig2 protein, mouseOligodendrocyte Transcription Factor 2OligonucleotidesCRISPR/Cas9Epitope taggingGene targetingGenome editingGlioblastomaHomologous recombinationNeural stem cellTranscription factor

Identifiers

PMID28096221
PMCPMC5312033
OpenAlexW2574894022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.